Suppr超能文献

Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations.

作者信息

Di Caro Antonino, Cunha Flavia, Petrosillo Nicola, Beeching Nicholas J, Ergonul Oner, Petersen Eskild, Koopmans Marion P G

机构信息

European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Laboratory of Microbiology, National Institute for Infectious Diseases 'Lazzaro Spallanzani', Rome, Italy; Department of Molecular Medicine, San Matteo Hospital, University of Pavia, Pavia, Italy.

European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Department of Infectious Diseases, Coimbra Hospital and University Centre, Coimbra, Portugal.

出版信息

Clin Microbiol Infect. 2021 Jun;27(6):823-826. doi: 10.1016/j.cmi.2021.03.011. Epub 2021 Mar 29.

Abstract
摘要

相似文献

1
Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations.
Clin Microbiol Infect. 2021 Jun;27(6):823-826. doi: 10.1016/j.cmi.2021.03.011. Epub 2021 Mar 29.
2
Vaccination of Pregnant Women Against COVID-19.
Neoreviews. 2021 Sep;22(9):e570-e573. doi: 10.1542/neo.22-9-e570.
3
Genetic Variants of SARS-CoV-2-What Do They Mean?
JAMA. 2021 Feb 9;325(6):529-531. doi: 10.1001/jama.2020.27124.
4
How to redesign COVID vaccines so they protect against variants.
Nature. 2021 Feb;590(7844):15-16. doi: 10.1038/d41586-021-00241-6.
5
Pfizer COVID vaccine protects against worrying coronavirus variants.
Nature. 2021 May;593(7859):325-326. doi: 10.1038/d41586-021-01222-5.
6
Neutralizing SARS-CoV-2.
Elife. 2020 Dec 15;9:e64496. doi: 10.7554/eLife.64496.
7
Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
Expert Rev Vaccines. 2021 Sep;20(9):1051-1057. doi: 10.1080/14760584.2021.1960161. Epub 2021 Aug 6.
10
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
J Infect Dis. 2021 Feb 3;223(2):189-191. doi: 10.1093/infdis/jiaa637.

引用本文的文献

2
Determination of COVID-19 PCR positivity and mutation status in coronaVac vaccinated individuals in Turkey.
Turk J Med Sci. 2022 Jun;52(3):541-546. doi: 10.55730/1300-0144.5344. Epub 2022 Jun 16.
3
SARS-CoV-2 coinfections with variant genomic lineages identified by multiplex fragment analysis.
Front Genet. 2022 Sep 26;13:942713. doi: 10.3389/fgene.2022.942713. eCollection 2022.
5
Immune Response to SARS-CoV-2 Vaccines.
Biomedicines. 2022 Jun 21;10(7):1464. doi: 10.3390/biomedicines10071464.
7
Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion.
Microbiol Spectr. 2022 Apr 27;10(2):e0181421. doi: 10.1128/spectrum.01814-21. Epub 2022 Mar 16.
10
Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike.
iScience. 2022 Jan 21;25(1):103589. doi: 10.1016/j.isci.2021.103589. Epub 2021 Dec 10.

本文引用的文献

1
Interpreting vaccine efficacy trial results for infection and transmission.
Vaccine. 2021 Jul 5;39(30):4082-4088. doi: 10.1016/j.vaccine.2021.06.011. Epub 2021 Jun 12.
2
SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity.
Lancet Infect Dis. 2021 Aug;21(8):1070. doi: 10.1016/S1473-3099(21)00262-0. Epub 2021 May 19.
3
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.
Nature. 2021 May;593(7857):142-146. doi: 10.1038/s41586-021-03471-w. Epub 2021 Mar 29.
4
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
5
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
6
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.
Science. 2021 Mar 12;371(6534):1139-1142. doi: 10.1126/science.abf6950. Epub 2021 Feb 3.
7
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.
Cell Rep Med. 2021 Feb 16;2(2):100204. doi: 10.1016/j.xcrm.2021.100204. Epub 2021 Jan 26.
8
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
Lancet. 2021 Feb 6;397(10273):452-455. doi: 10.1016/S0140-6736(21)00183-5. Epub 2021 Jan 27.
9
Insights from SARS-CoV-2 sequences.
Science. 2021 Jan 29;371(6528):466-467. doi: 10.1126/science.abf3995.
10
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.
Science. 2021 Jan 15;371(6526):288-292. doi: 10.1126/science.abe9728. Epub 2020 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验